Serotonin and noradrenaline reuptake inhibitors in animal models of pain

Human Psychopharmacology

Volumn 19, Issue SUPPL. 1, 2004, Pages

  Mochizucki, Daisuke ^a  

^a Scientific Affairs Department   (Japan)

Author keywords

Animal models; Antidepressant drugs; Milnacipran; Pain; SNRI

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; AMITRIPTYLINE; CITALOPRAM; DESIPRAMINE; DULOXETINE; FLUOXETINE; FLUVOXAMINE; FORMALDEHYDE; IMIPRAMINE; KETANSERIN; MAPROTILINE; MILNACIPRAN; NISOXETINE; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PRAZOSIN; SEROTONIN; SEROTONIN 2 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; CHRONIC PAIN; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFICACY; DRUG POTENCY; DRUG RESEARCH; HERPES SIMPLEX VIRUS 1; MOUSE; NERVE INJURY; NERVE LIGATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; REVIEW; SCIATIC NERVE; SEROTONINERGIC SYSTEM; SPINAL NERVE; SYMPTOM; TREATMENT FAILURE;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANTIDEPRESSIVE AGENTS; DISEASE MODELS, ANIMAL; HERPES SIMPLEX; MICE; NOREPINEPHRINE; PAIN; RATS; SEROTONIN UPTAKE INHIBITORS;

EID: 6344285317     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.620     Document Type: Review

References (29)

1. Bennett GJ, Xie YK. 1988. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87-107.
2. Briley M, Moret C. 2003. Fibromyalgia syndrome: an overview of potential drug targets. IDrugs 6: 668-673.
3. Dubuisson D, Dennis SG. 1977. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4: 161-174.
4. Esser MJ, Sawynok J. 1999. Acute amitriptyline in a rat model of neuropathic pain: differential symptom and route effects. Pain 80: 643-653.
5. Fields HL, Heinricher MM, Mason P. 1991. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 14: 219-245.
6. Fishbain D. 2000. Evidence-based data on pain relief with antidepressants. Ann Med 32: 305-316.
7. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. 2000. Evidence-based data from animal and human experimental studies on pain relief with antidepressants: a structured review. Pain Med 1: 310-316.
8. Holden JE, Pizzi JA. 2003. The challenge of chronic pain. Adv Drug Deliv Rev 55: 935-948.
9. Hunskaar S, Hole K. 1987. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30: 103-114.
10. Iyengar S, Bymaster F, Wong D, Simmons R, Ahmad L. 2002. Efficacy of the selective serotonin and norepinephrine reuptake inhibitor, duloxetine, in the formalin model of persistent pain. Pain Med 3: 177.
11. Kim SH, Chung JM. 1992. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50: 355-363.
12. Kranzler JD, Gendreau JF, Rao SG. 2002. The psychopharmacology of fibromyalgia: a drug development perspective. Psychopharmacol Bull 36: 165-213.
13. Kuraishi Y, Takasaki I, Nojima H, Shiraki K, Takahata H. 2004. Effects of the suppression of acute herpetic pain by gabapentin and amitriptyline on the incidence of delayed postherpetic pain in mice. Life Sci 74: 2619-2626.
14. Lang E, Hord AH, Denson D. 1996. Venlafaxine hydrochloride (Effexor) relieves thermal hyperalgesia in rats with an experimental mononeuropathy. Pain 68: 151-155.
15. Marchand F, Alloui A, Pelissier T, et al. 2003. Evidence for an anti-hyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat. Brain Res 980: 117-120.
16. Max MB. 1994. Treatment of post-herpetic neuralgia: antidepressants. Ann Neurol 35(Suppl.): S50-S53.
17. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. 1992. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326: 1250-1256.
18. Otsuki T, Nakahama H, Niizuma H, Suzuki J. 1986. Evaluation of the analgesic effects of capsaicin using a new rat model for tonic pain. Brain Res 365: 235-240.
19. Sánchez C, Owens M. 2003. Effect of the SSRI, escitalopram, and non-selective 5-HT reuptake inhibitors in an animal model of pain. In 42nd Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico.
20. Shin SW, Eisenach JC. 2004. Peripheral nerve injury sensitizes the response to visceral distension but not its inhibition by the antidepressant milnacipran. Anesthesiology 100: 671-675.
21. Stahl SM. 2002. Does depression hurt? J Clin Psychiatry 63: 273-274.
22. Staiger TO, Gaster B, Sullivan MD, Deyo RA. 2003. Systematic review of antidepressants in the treatment of chronic low back pain. Spine 28: 2540-2545.
23. Suzuki T, Mashimo T. 2004. Antiallodynic effects of milnacipran. In 24th Collegium ofinternationale Neuro-Psychopharmacologicum Congress, Paris, France.
24. Takasaki I, Andoh T, Nitta M, et al. 2000a. Pharmacological and immunohistochemical characterization of a mouse model of acute herpetic pain. Jpn J Pharmacol 83: 319-326.
25. Takasaki I, Andoh T, Shiraki K, Kuraishi Y. 2000b. Allodynia and hyperalgesia induced by herpes simplex virus type-1 infection in mice. Pain 86: 95-101.
26. Tura B, Tura SM. 1990. The analgesic effect of tricyclic antidepressants. Brain Res 518: 19-22.
27. Wall PD, Melzack R (eds). 1999. Textbook of Pain, 4th edn. Churchill Livingston: New York.
28. Yasuda T, Iwamoto T, Ohara M, et al. 1999. The novel analgesic compound OT-7100 (5-n-butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo[1,5-a]pyrimidine) attenuates mechanical nociceptive responses in animal models of acute and peripheral neuropathic hyperalgesia. Jpn J Pharmacol 79: 65-73.
29. Yokogawa F, Kiuchi Y, Ishikawa Y, et al. 2002. An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesth Analg 95: 163-168.